Peter Sieling
9Patents
2h-index
19Co-inventors
48Inventor score
Filing activity: Oct 13, 1994 → May 14, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5853737A | Method for inducing a CD1-restricted immune response | Chemistry; Metallurgy | 16 | Expired |
| US11298414B2 | Cellular adjuvants for viral infection | Chemistry; Metallurgy | 3 | Active |
| US10252269B2 | Methods of sorting activated T cells using three dimensional dielectrophoresis | Physics | 1 | Active |
| US12016883B2 | Primary T-cell expansion | Chemistry; Metallurgy | 0 | Active |
| US12220452B2 | Cellular adjuvants for viral infection | Chemistry; Metallurgy | 0 | Active |
| US12290558B2 | SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogens | Chemistry; Metallurgy | 0 | Active |
| US11857620B2 | Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus | Chemistry; Metallurgy | 0 | Active |
| US12329809B2 | Cellular adjuvants for viral infection | Chemistry; Metallurgy | 0 | Active |
| US12350323B2 | Cellular adjuvants for viral infection | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.